ArticleOphthalmology and therapy2026

Beyond Cost: Faricimab as a Driver of Service Efficiency and Quality in Neovascular Age-Related Macular Degeneration Care.

Yaneth Gil-Rojas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.